Profiling protective antibody responses against infectious diseases
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:0 publications
Grant number: GA475920
Grant search
Key facts
Disease
COVID-19, UnspecifiedStart & end year
2027.02031.0Known Financial Commitments (USD)
$1,864,781.77Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
.Research Location
AustraliaLead Research Institution
University of MelbourneResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Antibodies are a vital component of the immune response required for protection and control of infectious diseases. My research program will determine how antibodies contribute to protection and control of some of the world’s most deadly infectious pathogens (COVID-19, Influenza, Malaria and Mycobacterium Tuberculosis) in order to develop improved antibody-based vaccines, therapies and diagnostic tools.